Chemoinformaics analysis of GANODERIC-ACIDS-A-Z
Molecular Weight | 472.71 | nRot | 5 |
Heavy Atom Molecular Weight | 424.326 | nRig | 22 |
Exact Molecular Weight | 472.355 | nRing | 4 |
Solubility: LogS | -3.724 | nHRing | 0 |
Solubility: LogP | 5.013 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 85.3141 |
nHD | 3 | BPOL | 49.0219 |
QED | 0.315 |
Synth | 4.907 |
Natural Product Likeliness | 3.444 |
NR-PPAR-gamma | 0.927 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.621 |
Pgp-sub | 0.007 |
HIA | 0.047 |
CACO-2 | -5.072 |
MDCK | 0.0000204 |
BBB | 0.879 |
PPB | 0.966879 |
VDSS | 0.842 |
FU | 0.0254647 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.595 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.92 |
CYP2c9-inh | 0.159 |
CYP2c9-sub | 0.814 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.353 |
CYP3a4-inh | 0.067 |
CYP3a4-sub | 0.372 |
CL | 5.422 |
T12 | 0.019 |
hERG | 0.039 |
Ames | 0.018 |
ROA | 0.054 |
SkinSen | 0.111 |
Carcinogencity | 0.015 |
EI | 0.015 |
Respiratory | 0.927 |
NR-Aromatase | 0.766 |
Antiviral | No |
Prediction | 0.593907 |